Finding studies
Finding studies
Take this into the appointment.
Saves the questions and what to expect into your notes, next to the visit they belong to.
Daiichi Sankyo Contact for Clinical Trial Information
CONTACT
Lead
Daiichi Sankyo
With
The primary objective of this study is to evaluate the overall survival (OS) benefit of I-DXd compared with investigator's choice of chemotherapy (ICC). The key secondary objectives of the study will evaluate the progression-free survival (PFS) and objective response rate (ORR) benefit of I-DXd compared with ICC.
Age
18–any
Sex
ALL
Healthy volunteers
Not accepted